Trivalent P2-VP8

BIOLOGICAL2 trials

Sponsors

PATH, Centre for Infectious Disease Research in Zambia

Conditions

DiarrheaDiarrhea RotavirusRotavirus Vaccine

Phase 2

Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine

CompletedNCT04344054

PATHRotavirus Vaccine

Start: 2021-02-22End: 2022-09-09Updated: 2022-11-29

Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa

CompletedNCT04658914

Centre for Infectious Disease Research in ZambiaDiarrhea, Diarrhea Rotavirus

Start: 2021-04-15End: 2023-01-30Updated: 2025-05-15